In a report released today, Adam Maeder from Piper Sandler maintained a Hold rating on Vicarious Surgical (RBOT – Research Report), with a price target of $4.00. The company’s shares closed yesterday at $1.74.
According to TipRanks, Maeder is a 5-star analyst with an average return of 19.2% and a 58.05% success rate. Maeder covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Axonics Modulation Technologies, and Shockwave Medical.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Vicarious Surgical with a $6.67 average price target.
See the top stocks recommended by analysts >>
The company has a one-year high of $4.76 and a one-year low of $1.36. Currently, Vicarious Surgical has an average volume of 263.5K.
Based on the recent corporate insider activity of 118 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of RBOT in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
D8 Holdings Corp is a blank check company.
